Beranda › Glioma Pontin Intrinsik Difus
Uji klinis Glioma Pontin Intrinsik Difus yang merekrut di AS
23 studi untuk Glioma Pontin Intrinsik Difus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Washington, DC11 studi
- Cincinnati, OH10 studi
- Houston, TX10 studi
- Seattle, WA10 studi
- Philadelphia, PA10 studi
- Columbus, OH10 studi
- Chicago, IL9 studi
- Boston, MA9 studi
- Durham, NC9 studi
- Aurora, CO8 studi
- Miami, FL6 studi
- Ann Arbor, MI6 studi
- St. Louis, MO5 studi
- Atlanta, GA4 studi
- Birmingham, AL3 studi
- Los Angeles, CA3 studi
- New York City, NY3 studi
Berdasarkan negara bagian
- Alabama3 studi
- California5 studi
- Colorado8 studi
- Distrik Columbia11 studi
- Florida7 studi
- Georgia4 studi
- Illinois9 studi
- Massachusetts9 studi
- Michigan6 studi
- Missouri5 studi
- New York3 studi
- North Carolina9 studi
- Ohio12 studi
- Pennsylvania12 studi
- Texas11 studi
- Washington10 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Menerima pesertaFase 2
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Menerima pesertaFase 1/2
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT04870944Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Menerima pesertaFase 1
36 Months · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07076498NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Menerima pesertaFase 1
Usia 3 hingga 25 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
Menerima pesertaStudi observasional
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Menerima pesertaFase 1/2
Hingga usia 26 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06465199Study of Olutasidenib and Temozolomide in HGG
Menerima pesertaFase 2
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Menerima pesertaFase 2
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Menerima pesertaFase 2
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07680439Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Menerima pesertaFase 1
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06624371C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Menerima pesertaFase 1
12 Months – 25 Years · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT04099797Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Menerima pesertaFase 1/2
Usia 4 hingga 39 · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
Menerima pesertaFase 2
Usia 2 hingga 39 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Menerima pesertaFase 2
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Menerima pesertaFase 1
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT04185038A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Menerima pesertaFase awal 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04655404rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Menerima pesertaFase 1
12 Months – 18 Years · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT04943848FUS Etoposide for DMG
Menerima pesertaFase 1
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT05762419Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 8 Des 2025 · NCT05956821International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT03101813Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Menerima pesertaStudi observasional
Hingga usia 21 · Semua jenis kelamin · Diperbarui 20 Agu 2024 · NCT01106794xPedite: A Study to Expedite DIPG and DMG Research
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 30 Apr 2024 · NCT06140719Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.